• GSK 'real world' drug test has second success in asthma biospectrumasia
    May 15, 2017
    The study showed the drug, which is marketed as Relvar in Europe, was superior in controlling symptoms of asthma compared to usual care, based on a standardized questionnaire filled out by patients.
PharmaSources Customer Service